For the complete Publications Index, 1983-2002, call 1-888-898-2229.

Scientific Publications

-2002-

  1. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol 2002 Jan 1;155(1):17-25.

  2. Shaw GM, Nelson V, Moore CA. Prepregnancy body mass index and risk of multiple congenital anomalies. Am J Med Genet; 107(3) 2002:253-255.

  3. Shaw GM, Lammer EJ, Huiping Z, Baker MW, Neri E, Finnell RH. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet;108(1)2002:1-6.

-2001-

  1. Shaw GM. Adverse human reproductive outcomes and electromagnetic fields: A brief summary of the epidemiologic literature. Bioelectromagnetics;22(S5): S5-S18.

  2. Shaw GM, Todoroff K, Carmichael SL, Schaffer DM, Selvin S. Lowered weight gain during pregnancy and risk of neural tube defects among offspring. Int. J Epidemiol.;30(1):60-65.

  3. Croen LA, Todoroff K, Shaw GM. Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Am J Epidamiol.;153(4):325-331.

  4. Shaw GM, Savitz DA, Nelson V, Throp Jr. JM. Role of structural birth defects in preterm delivery. Paediatr Perinatol Epidemiol;15(2): 106-109.

  5. Hartsfield JK Jr., Hickman TA, Everett ET, Shaw GM, Lammer EJ, Finnell RA. Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. Am J Med Genet;102(1):21-4.

  6. Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr;138:804-10.

  7. Croen LA, Grether JK, Selvin S. The epidemiology of mental retardation of unknown cause. Pediatrics;107(6):E86.

  8. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol;49(5):597-606.

  9. Croen LA, Shaw GM, Barber RC, Baker MM, Finnell RH, Lammer EJ. Apolipoprotein B and apolipoprotein E genotypes and sporadic holoprosencephaly. Am J Med Genet; Dec. 5 Online.

  10. Shaw GM, Selvin S, Carmichael SL, Schaffer DM, Nelson V, Neri E. Assessing combined chemical exposures as risk factors for neural tube defects. Repro Toxicol;15(6):631-635.

     

    -2000-

  1. Croen LA, Shaw GM, Lammer EJ. Risk factors for cytogenetically normal holoprosencephaly in California: a population-based case-control study. Am J Med Genet;90:320-325.

  2. Shaw GM, Barber R, Todoroff K, Lammer EJ, Finnell RH. Microsatellites proximal to leptin and leptin receptor as risk factors for Spina Bifida. Teratology;61:231-5.

  3. Carmichael SL, Shaw GM. Maternal life event stress and congenital anomalies. Epidemiology;1:30-5.

  4. Todoroff K, Shaw GM. Prior spontaneous abortion, prior elective termination, interpregnancy interval, and risk of neural tube defects. Am J Epidemiol;151:(5)505-11.

  5. Windham GC, Shaw GM, Todoroff K, Swan SH. Miscarriage and use of multi-vitamins or folic acid. Am J Med Genet; 90:261-2.

  6. Shaw GM, Todoroff K, Finnell RH, Lammer EJ. Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology;61:376-381.

  7. Grether JK. Possible decrease in prevalence of cerebral palsy in premature infants. (Letter) J Pediatr;136(1):133.

  8. Nanni L, Croen LC, Lammer EJ, Muenke M. Holoprosencephaly: molecular study of a California population. Am J Med Genetics;90:315-9.

  9. Shaw GM, Croen LA, Todoroff K, Tolarova MM. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies.Am J Med Genetics;93(3):188-93.

  10. Shaw GM, Todoroff K, Schaffer DM, Selvin S. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Paediatr Perinatol Epidemiol;14(3):234-9.

  11. Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ.  Polymorphisms in genes involved in folate metabolism as maternal risk factors for down syndrome.  Am J Human Genetics;67(3):623-630.

  12. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB.  Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstetrics and Gynecology;183(3):717-25.

  13. Finnell RH, Gelineau-van Waes J, Bennett GD, Barber RC, Wlodarczyk B, Shaw GM, Lammer EJ, Piedrahita JA, Eberwine JH.  Genetic basis of susceptibility to environmentally induced neural tube defects.  Ann NY Acad Sci;919:261-77.

  14. Torfs CP, Christianson RE.  Effect of maternal smoking and coffee consumptioin on the risk of having a recognized Down syndrome pregnancy.  Am J epidemiol;152(12):1185-91.

  15. Harris JA, Robert E, Klln. Epidemiologic characteristics of kidney malformations. Eur J Epidemiol;16(11):985-992.

    -1999-

  1. Shaw GM, Nelson V, Todoroff K, Wasserman CR, Neutra RR. Maternal periconceptional use of electric bed-heating devices and risk for neural tube defects and orofacial clefts. Teratology;60:124-129.

  2. Torfs CP, Christianson RE. Maternal risk factors and major associated defects in infants with Down syndrome. Epidemiol;10(3):264-270.

  3. Schieve LA, Perry GS, Cogswell ME, Scanlon KS, Rosenberg D, Carmichael SL, Ferre C. Validity of self-reported pregnancy delivery weight: An analysis of the 1988 National Maternal and Infant Health Survey. Am J of Epidem;150:(9)947-956.

  4. Grether JK, Eaton A, Redline R, Bendon R, Benirschke K, Nelson KB. Reliability of placental histology using archived specimens. Paediatr Perinatol Epidemiol;13:489-495.

  5. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, Hemphill S, Tsaroucha G, Rushing J, Levin S. Validity and reproducibility of a food frequency interview in a multi-cultural epidemiologic study. Annals of Epidemiol;9:314-324.

  6. Strick B, Shaw GM, Harris JA. An anthropological approach to inform epidemiologic research on birth defects. Teratology;60:109-111.

  7. Velie EM, Block G, Shaw GM, Samuels SJ, Schaffer DM, Kulldorft M. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J of Epidem;150(6):605-616.

  8. Nelson KB, Grether JK. Selection of neonates for neuroprotective therapies: One set of criteria applied to a population. Arch Pediatr Adolesc Med;153:393-398.

  9. Shaw GM, Lammer EJ. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Peds;134(3):298-303.

  10. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet;86:242-244.

  11. Lam PK, Torfs CP, Brand RJ. A low pregnancy body mass index is a risk factor for an offspring with gastroschisis. Epidemiol;10(6):717-721.

  12. Shaw GM, Wasserman CR, OMally CD, Nelson V, Jackson RJ. Maternal pesticide exposures from multiple sources and selected congenital anomalies. Epidemiol;10:60-66.

  13. Shaw GM, Todoroff K, Finnell RH, Lammer EJ, Rozen R. Infant methionine synthase variants and risk for spina bifida. J Med Genet;36:86-87.

  14. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr;11(6):487-491.

  15. Malcoe LH, Shaw GM, Lammer EJ, Herman A. Congenital anomalies and mortality risk in white and black infants. Am J Pub Health;89:887-892.

  16. Shaw GM, Velie EM, Katz EA, Morland KB, Schaffer DM, Nelson V. Maternal occupational and hobby chemical exposures as risk factors for neural tube defects. Epidemiol;10:124-129.

  17. Cieri MV, Arnold GL, Torfs CP. Malrotation in conjunction with esophageal atresia/tracheo-esophageal fistula. Teratology;60:114-116.

  18. Trembath D, Sherbondy AL, Vandyke DC, Shaw GM, Todoroff K, Lammer EJ, Finnell RH, Marker S, Lerner G, Murray JC. Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology;59:331-341.

  19. Rozen R, Fraser FC, Shaw GM. Decreased proportion of female newborns homozygous for the C677T mutation in methylenetetrahydrofolate reductase. Am J Med Genet;83:142-143.

  20. Barber RC, Lammer EJ, Shaw GM, Greer KA, Finnell RH. The role of folate transport and metabolism in neural tube defect risk. Mol Genet Metab;66:1-9.

  21. Shaw GM, Finnell RH, Todoroff K, Rozen R, Lammer EJ. Maternal vitamin use, infant C677T mutation in MTHFR, and isolated cleft palate risk. Am J Med Genet;85:84-85.

  22. Shaw GM, Todoroff K, Schaffer DM, Selvin S. Periconceptional nutrient intake and risk for neural tube defect-affected pregnancies. Epidemiol;10:711-716.

  23. Grether JK, Nelson KB, Dambrosia JM, Phillips TM. Interferons and cerebral palsy. J Pediatr;134(3):324-332.

    -1998-

  1. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet; 80:196-8.

  2. Savage AR, Petersen MB, Pattay D, Taft L, Allran K, Freeman SB, Karadima G, Avramopoulos D, Torfs CP, et. al. Elucidating the mechanisms of paternal non-disjunction of chromosome 21 in humans. Hum Mol Genet;7(8):1221-1227.

  3. Tolarova MM, Cervenka J. Classification and Birth Prevalence of Orofacial Clefts. Am J Med Genet; 75:126-137.

  4. Torfs CP, Christianson RE. Anomalies in Down syndrome individuals in a large population-based registry. Am J Med Genet;77:431-438.

  5. Torfs CP, Lam PK, Schaffer DM, Brand RJ. Association between mothers nutrient intake and their offsprings risk of gastroschisis. Teratology;58:241-250.

  6. Croen LA, Shaw GM, Wasserman CR, Tolarova MM. Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Genet;79:42-47.

  7. Wasserman CR, Shaw GM, Selvin S, Gould JB, Syme SL. Socioeconomic status, neighborhood social conditions and neural tube defects. Am J Pub Health;88:1674-1680.

  8. Finnell RH, Greer LA, Barber RA, Piedrahita JA, Shaw GM, Lammer EJ. Neural tube and craniofacial defects with special emphasis on folate pathway genes. Crit Rev Oral Biology Med;9:38-53.

  9. Shaw GM, Wasserman CR, Murray JC, Lammer EJ. Infant TGF-alpha genotype, orofacial clefts, and maternal periconceptional multivitamin use. Cleft Palate Craniofac J;35:366-370.

  10. Barber RC, Shaw GM, Lammer EJ, Greer KA, Lacey SW, Wasserman CR, Finnell RH. Lack of association between mutations in the folate receptor-a gene and spina bifida. Am J Genet;76:310-317.

  11. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J of Epidem;148(1):30-37.

  12. Schaffer DM, Velie EM, Shaw GM, Todoroff KP. Energy and nutrient intakes and health practices of Latinas and white non-Latinas in the 3 months before pregnancy. J Am Diet Assoc;98(8):876-884.

  13. Shaw GM, Todoroff K, Velie E, Lammer E. Maternal illness, including fever, and medication use as risk factors for neural tube defects. Teratology;57:1-7.

  14. Grether JK, Hoogstrate J, Selvin S, Nelson KB. Magnesium sulfate tocolysis and risk of neonatal death. Am J Obstet Gynecol;178:1-6.

  15. Grether JK, Selvin S, Hoogstrate J, Nelson KB. Tocolytic magnesium sulfate: Are the epidemiologic data reassuring? (Reply). Am J Obstet Gynecol;179(1):280.

  16. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol;44(4):665-675.

  17. Nelson KB, Grether JK. Potentially birth asphyxiating conditions and risk of spastic cerebral palsy in infants of normal birthweight. Am J Obstet Gynecol;179:507-513.

  18. Kallen B, Robert E, Harris JA. Associated malformations in infants and fetuses with upper and lower neural tube defects. Teratology;57(2):56-63.

    -1997-

  1. Werler MM, Cragan JD, Wasserman CR, Shaw GM, Erikson JD, Mitchell AA. Multivitamin supplementation and multiple births. Am J Genet;71:93-96.

  2. Shaw GM, Lammer EJ. Incorporating molecular genetic variation and environmental exposures into epidemiologic studies of congenital anomalies. Repro Toxicol;11:(2/3)275-280.

  3. Shaw GM, Lieberman RF, Todoroff K, Wasserman CR. Low birth weight, preterm delivery, and periconceptional vitamin use. J Peds;130(6):1013-1014.

  4. Shaw GM, Velie E, Schaffer D. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies? Teratology;56:295-299.

  5. Robert E, Harris JA, Klln B. The epidemiology of preaxial limb malformations. Repro Toxicol;11(5):653-662.

  6. Torfs CP, Honor LH, Curry CJ. Is there an association of Down syndrome and omphalocele? Am J Med Genet;73(4):393-396.

  7. Harris JA, Robert E, Klln B. The epidemiology of choanal atresia with special reference to the CHARGE association. Pediatrics;99(3)363-7.

  8. Schecter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinatol Epidemiol;11:407-424.

  9. Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. AJPH;87(9):1467-1471.

  10. Grether JK, Nelson KB. Maternal infections and cerebral palsy in infants of normal birthweight. JAMA;278:207-211.

  11. Croen LA, Shaw GM, Sanbonmatsu L, Selvin S, Buffler PA. Maternal residential proximity to hazardous waste sites and risk for selected congenital malformations. Epidemiology;8(4):337-339.

  12. Shaw GM, Todoroff K, Lammer EJ. NTD phenotypes in infants and fetuses whose mothers used multivitamins containing folic acid in early pregnancy compared to those who did not. Am J Med Genet;70:330-331.

  13. Emery III ES, Eaton A, Grether JK, Nelson KB. Assessment of gestational age using birth certificate data compared with medical record data. Paediatr Perinatol Epidemiol;11:313-321.

  14. Harris JA, James L. State-by-state cost of birth defects1992. Teratology;56(1/2):11-16.

  15. Cragen JD, Roberts HE, Edmonds LD, Khoury MJ, Kirby RS, Shaw GM, Velie EM, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosisUnited States, 1985-1994. Teratology;56(1/2):37-49.

  16. Robert E, Klln B, Harris JA. The epidemiology of diaphragmatic hernia. Eur J Epidemiology;13:655-673.

  17. Shaw GM, Velie EM, Schaffer D, Lammer EJ. Periconceptional intake of vitamin A among women and risk of neural tube defect-affected pregnancies. Teratology;55:132-133.

  18. Booth VJ, Nelson KB, Dambrosia JM, Grether JK. What factors influence whether placentas are submitted for pathologic examination? Am J Obstet Gynecol;176(3):567-571.

  19. Bishop J, Heuther C, Torfs CP, Lorey F, Deddens J. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am J of Epidemiol; 145(2):134-147.

  20. Nelson KB, Grether JK. Cerebral palsy in low birth weight infants: etiology and strategies for prevention. Ment Retard Devel Res Rev;3(2):112-117.

  21. Grether JK, Hirtz D, McNellis D, Nelson KB, Rouse DJ. Tocolytic magnesium sulfate and paediatric mortality (correspondence). Lancet;351:292.

  22. Nelson KB, Grether JK. More on prenatal magnesium sulfate and risk of cerebral palsy (letter). JAMA;278(18):149.

  23. Tolarova MM, Harris JA, Ordway DE, Vargervik K. Birth Prevalence, Mutation Rate, Sex Ratio, Parents Age, and Ethnicity in Apert Syndrome. Am J Med Genet; 72:394-8.

-1996-

  1. OMalley CD, Shaw GM, Wasserman CR, Lammer EJ. Epidemiologic characteristics of conotruncal heart defects in California, 1987-1988. Teratology;53:374-377.

  2. Robert E, Harris JA, Robert O, Selvin S. Case-control study on maternal residential proximity to high voltage power lines and congenital malformations in France. Paediatr Perinatol Epidemiol;10:32-38.

  3. Robert E, Klln B, Harris JA. The epidemiology of orofacial clefts. 1. Some general epidemiological characteristics. J Craniofac Genet Dev Biol;16:234-241.

  4. Robert E, Klln B, Harris JA. The epidemiology of orofacial clefts. 2. Associated malformations. J Craniofac Genet Dev Biol;16:242-248.

  5. Shaw GM, Velie EM, Moreland K. Parental recreational drug use and risk for neural tube defects. Am J Med Epidemiol;144(12):1155-1160.

  6. Harris JA, Klln B, Robert E. The epidemiology of anotia and microtia. Am J Med Genet; 33:809-813.

  7. Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJR. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology;54(2):84-92.

  8. Velie EM, Shaw GM. The impact of prenatal diagnosis and elective termination of prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J of Epidemiol;144(5):473-479.

  9. Croen LA, Shaw GM, Lammer EJ. Holoprosencephaly: Epidemiologic and clinical characteristics of a California population. Am J Med Genet;64:465-472.

  10. Klln B, Robert E, Harris JA. The descriptive epidemiology of anophthalmia and microphthalmia. Epidemiol;25(5):1-8.

  11. Wasserman CR, Shaw GM, OMalley CD, Tolarova MM, Lammer EJ. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology;53:261-267.

  12. Grether JK, Nelson KB, Emery III ES, Cummins SK. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J of Peds;128:407-414.

  13. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA;275(14):1093-1096.

  14. Shaw GM, Wasserman CR, Lammer EJ, OMalley CD, Murray JC, Basart AM, Tolarova MM. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Med Genet; 58 (3): 551-561.

  15. Heuther CA, Martin RLM, Stoppelman SM, DSzoua S, Bishop JK, Torfs CP, et. al. Sex ratios in fetuses and liveborn infants with autosomal aneuploidy. Am J Med Genet;63:

    492-500.

  16. Shaw GM, Wasserman CW, Block G, Lammer EJ. High maternal vitamin A intake and risk of anomalies of structures with a cranial neural crest cell contribution (letter). Lancet;347:899-900.

  17. Khoury MJ, Shaw GM, Moore CA, Lammer EJ, Mulinare J. Does periconceptional multivitamin use reduce the risk of neural tube defects associated with other defects? Am J Med Genet;61:30-36.

  18. Botto LD, Olney RS, Mastroiacovo P, Khoury MJ, Moore CA, Alo CJ, Costa P, Edmonds LD, Flood TJ, Harris JA, Howe HL, Olsen CL, Panny SR, Shaw GM. Chorionic villus sampling and transverse digital deficiencies: Evidence for anatomic and gestational-age specificity of the digital deficiencies in two studies. Am J Med Genet;62(2):173-178.

  19. Nelson KB, Dambrosia JM, Ting YY, Grether JK. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. NEJM;334(10):613-618.

-1995-

  1. Torfs CP, Curry CJR, Bateson TF. Population-based study of tracheoesophageal fistula and esophageal atresia. Teratology;52(4): 220-232.

  2. Robert E, Francannet C, Shaw GM. Neural tube defects and maternal weight reduction in early pregnancy. Repro Toxicol;9(1):57-59.

  3. Harris JA, Shaw GM. Neural tube defectsWhy are rates high among populations of Mexican descent? Environ Health Perspect;103(Suppl 6):163-4.

  4. Shaw GM, OMalley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart and limb reduction defects among offspring. Am J Med Genet;59(4):536-545.

  5. Harris JA, Klln B, Robert E. Descriptive epidemiology of alimentary tract atresia. Teratology;52:15-29.

  6. Waitzman NJ, Romano PS, Scheffler RM, Harris JA. Economic costs of birth defects and cerebral palsy. MMWR;44(37):694-699.

  7. Takahashi ER, Shaw GM. Feasibility of collecting maternal blood and hair samples in a case-control study of congenital anomalies (letter). Epidemiol;6:469.

  8. Cragan JD, Roberts HE, Edmonds LD, Khoury JK, Kirby RS, Shaw GM, Velie EM, et. al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosisUnited States, 1985-1994. MMWR;44(SS-4):1-13.

  9. Shaw GM, Lammer EJ, Velie EM. Ovulation induction by clomiphene and neural tube defects (letter). Reproductive Toxicology;9(4):399-400.

  10. Shaw GM, Lammer EJ, Wasserman CR, OMalley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet;346:393-396.

  11. Tolarova M, Harris JA. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology;51(2):71-78.

  12. Croen LA, Shaw GM. Young maternal age and congenital malformations: A population-based study. AJPH;85(5):710-713.

  13. Shaw GM, Wasserman CR, OMalley CD, Lammer EJ, Finnell RH. Orofacial clefts and maternal anticonvulsant use (letter). Reproductive Toxicology;9(1):97-98.

  14. Romano PS, Waitzman NJ, Scheffler, RM, Pi RD. Folic acid fortification of grain: An economic analysis. (Study funded in part by the California Birth Defects Monitoring Program.) AJPH;85(5):667-676.

  15. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiol;6(3): 219-226.

  16. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics;95(2): 263-269.

  17. Olney RD, Khoury MJ, Alo CJ, Costa P, Edmonds LD, Flood TJ, Harris JA, et al. Increased risk for transverse digital deficiency after chorionic villus sampling: Results of the US multi-state case-control study, 1988-1992. Teratology;51(1):20-29.

    Abstracts Presented At Scientific Meetings

     

    2001

  1. Shaw GM. Epidemiologic characteristics of oral clefts. Presented at the National Birth Defects Prevention Network Meeting, San Antonio, TX.

  2. Shaw GM, Nelson V. Paternal occupational group and risk of offspring with neural tube defects. Presented at the National Birth Defects Prevention Network Meeting (poster), San Antonio, TX.

  3. Shaw GM, Todoroff K, Carmichael SL, Schaffer DM, Selvin S. Lowered weight gain during pregnancy and risk of neural tube defects among offspring. Presented at the National Birth Defects Prevention Network Meeting (poster), San Antonio, TX.

  4. Carmichael SL, Shaw GM, Neri E, Schaffer DM, Selvin S. Physical activity and risk of neural tube defects. Presented at the Society of Epidemiologic Research Meeting, Toronto, Canada.

  5. Shaw GM, Lammer EJ, Zhu H, Finnell RH. Maternal vitamin use, genetic variation of the infant reduced folate carrier gene and risk of spina bifida. Presented at the 3rd International conference on Homocysteine Metabolism, Sorrento, Italy.

  6. Ritz BR, Yu F, Shaw GM. Ambient air pollution and risk of birth defects in Southern California. Presented at the Society of Epidemiologic Research Meeting, Toronto, Canada.

  7. Shaw GM, Nelson V, Lammer EJ. Maternal occupational exposures and biotransformation genotypes as risks for congenital anomalies. Presented at the Society of Epidemiologic Research Meeting, Toronto, Canada.

  8. Shaw GM. Workshop on Environmental Contributors to Infant Mortality. Epidemiology and birth defects, invited presentation. NIH/NIEHS Chapel Hill, North Carolina.

2000

  1. Nelson KB, Grether JK, Dambrosia JM, Croen LA, Dickens BF, Hansen RL, Phillips TM. Neuropeptides and neurotrophins in neonatal blood of children with autism, mental retardation, or cerebral palsy. Presented at the Annual Meeting of the American Academy of Neurology, San Diego, CA.

  2. Deosaransingh K,Warmerdam BA, Harris JA. Evaluation of the department of defense database as a source for birth defects surveillance. Presented at the 2000 Maternal and Child Health Conference (poster), San Diego, CA.

  3. Shaw GM, Todoroff K, Carmichael SL, Schaffer DM, Selvin S. Lowered weight gain during pregnancy and risk of neural tube defects among offspring. Presented at the Society for Epidemiologic Research Annual Meeting, Seattle, WA.

  4. Carmichael SL, Shaw GM, Selvin S, Schaffer DM. Diet quality and risk of neural tube defects. Presented at the Society for Epidemiologic Research Annual Meeting, Seattle, WA.

  5. Shaw GM, Croen LA, Todoroff K, Tolarova MM. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies. Presented at the Society for Pediatric and Perinatal Epidemiologic Research Annual Meeting, Seattle, WA.

  6. Shaw GM, Nelson V. Paternal occupation and risk of neural tube defects. Presented at the Teratology Society Annual Meeting, Palm Beach, FL.

  7. Shaw GM, Croen LA, Todoroff K, Tolarova MM. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies. Presented at the Teratology Society Annual Meeting, Palm Beach, FL.

  8. Shaw GM, Todoroff K, Carmichael SL, Schaffer DM, Selvin S. Lowered weight gain during pregnancy and risk of neural tube defects among offspring. Presented at the Teratology Society Annual Meeting, Palm Beach, FL.

  9. Torfs CP, Christianson RE. Maternal body mass index as a risk factor for a clinically recognized pregnancy with Down syndrome. Presented at the Society for Epidemiologic Research Annual Meeting (poster), Seattle, WA.

  10. Torfs CP, Deosaransingh K. Gastroschisis prevalence rates: no secular trends in California, from 1984 to 1996. Presented at the Society for Epidemiologic Research Annual Meeting (poster), Seattle, WA.

  11. Shaw GM.  US collaborative studies investigation etiologies of orofacial clefts.  Presented at International Collaborative Research on Craniofacial Anomalies, Geneva, Switzerland.

1999

  1. Shaw GM. Maternal vitamin use, infant mutation in MTHFR and cleft palate risk. Presented at the Annual Meeting of Teratology Society, Keystone, CO.

  2. Shaw GM. Maternal periconceptional use of electric bed heating devices and risk for neural tube defects and orofacial defects. Presented at the Annual Meeting for Society of Epidemiologic Research, Baltimore, MD.

  3. Shaw GM. Maternal height and prepregnancy weight as risk factors for selected congenital anomalies. Presented at the Annual Meeting for Society of Epidemiologic Research, Baltimore, MD.

  4. Shaw GM. Maternal vitamin use, infant mutation in MTHFR and cleft palate risk. Presented at Society for Pediatric and Perinatal Epidemiologic Research, Baltimore, MD.

  5. Shaw GM. Maternal vitamin intake and risk of CLP or CP in offspring. Presented at Prevention of Craniofacial Anomalies Workshop, NIH/NIDCR, Betheseda, MD.

  6. Croen LA . Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Presented at Bay Area Reproductive Epidemiology and the Environmental Health and Investigations Branch, Oakland, CA.

  7. Shaw GM. Epidemiology and folate-related susceptibility alleles. Presented at the Current Status of Knowledge on Folate and Human Development, EPA, Durham, NC.

  8. Shaw GM. Disease-based registries. Rapporteur at Epidemiology in the Twenty-First Century, NIH/NIEHS, Raleigh, NC.

  9. Croen LA. Epidemiology of holoprosencephaly in California. Presented at Childrens Hospital Oakland Seminar series for Center for Research and the Annual Meeting for Stanford University Carter Centers for the Study of Holoprosencephaly, Oakland, CA and Stanford, CA.

  10. Shaw GM. Spina bifida phenotypes in infants or fetuses whose mothers were obese. Presented at the Annual Meeting of Teratology Society, Keystone, CO.

  11. Shaw GM. Human adverse reproductive outcomes and electromagnetic fields: A brief summary of the epidemiologic literature. Presented at the Electric and Magnetic Fields Program DHS Workshop, Berkeley, CA.

  12. Shaw GM. Gene-environment interaction studies in California: Whats old, whats new, whats next? Presented at the European Science Foundation Gene-environment interaction in early human development: demonstration project on orofacial clefts, Strassbourg, France.

  13. Croen LA. Estimating maternal drinking water nitrate exposure in a retrospective study. Presented at Society for Epidemiologic Research, Baltimore, MD.

  14. Carmichael SL, Shaw GM. Maternal life events and congenital anomalies. Presented at Society for Epidemiologic Research (poster), Baltimore, MD.

  15. Shaw GM. Obesity and NTDs. Presented at NTD 2000, an International Collaborative Meeting, Frankfurt, Germany.

  16. Wynne JW. Using registry data to launch epidemiological research. Presented at the Second Annual National Birth Defects Prevention Network, Washington DC.

     

    For the complete Publications Index, 1983-2001, call 1-888-898-2229.

     

    Back

    Home